[HTML][HTML] A clinical perspective of anti-fibrotic therapies for cardiovascular disease

L Fang, AJ Murphy, AM Dart - Frontiers in pharmacology, 2017 - frontiersin.org
Cardiac fibrosis are central to various cardiovascular diseases. Research on the
mechanisms and therapeutic targets for cardiac fibrosis has advanced greatly in recent …

Investigational drugs targeting cardiac fibrosis

F Roubille, D Busseuil, N Merlet… - Expert review of …, 2014 - Taylor & Francis
Fibrosis is an accumulation of proteins including collagen in the extracellular space, which
has previously been considered as irreversible damage in various cardiovascular diseases …

[HTML][HTML] Cardiac fibrosis: new insights into the pathogenesis

ZG Ma, YP Yuan, HM Wu, X Zhang… - International journal of …, 2018 - ncbi.nlm.nih.gov
Cardiac fibrosis is defined as the imbalance of extracellular matrix (ECM) production and
degradation, thus contributing to cardiac dysfunction in many cardiac pathophysiologic …

[HTML][HTML] Cardiac Fibrosis in heart failure: Focus on non-invasive diagnosis and emerging therapeutic strategies

S Ravassa, B López, TA Treibel, G San José… - Molecular Aspects of …, 2023 - Elsevier
Heart failure is a leading cause of mortality and hospitalization worldwide. Cardiac fibrosis,
resulting from the excessive deposition of collagen fibers, is a common feature across the …

[HTML][HTML] Targeting myocardial fibrosis—A magic pill in cardiovascular medicine?

A Scridon, AI Balan - Pharmaceutics, 2022 - mdpi.com
Fibrosis, characterized by an excessive accumulation of extracellular matrix, has long been
seen as an adaptive process that contributes to tissue healing and regeneration. More …

Cardiac fibrosis: potential therapeutic targets

S Park, NB Nguyen, A Pezhouman, R Ardehali - Translational Research, 2019 - Elsevier
Cardiovascular disease is a leading cause of mortality in the world and is exacerbated by
the presence of cardiac fibrosis, defined by the accumulation of noncontractile extracellular …

The pathogenesis of cardiac fibrosis

P Kong, P Christia, NG Frangogiannis - Cellular and molecular life …, 2014 - Springer
Cardiac fibrosis is characterized by net accumulation of extracellular matrix proteins in the
cardiac interstitium, and contributes to both systolic and diastolic dysfunction in many …

Towards better definition, quantification and treatment of fibrosis in heart failure. A scientific roadmap by the Committee of Translational Research of the Heart Failure …

RA de Boer, G De Keulenaer… - European journal of …, 2019 - Wiley Online Library
Fibrosis is a pivotal player in heart failure development and progression. Measurements of
(markers of) fibrosis in tissue and blood may help to diagnose and risk stratify patients with …

[HTML][HTML] Treatment of cardiac fibrosis: from neuro-hormonal inhibitors to CAR-T cell therapy

P Morfino, A Aimo, V Castiglione, C Gálvez-Montón… - Heart Failure …, 2023 - Springer
Cardiac fibrosis is characterized by the deposition of extracellular matrix proteins in the
spaces between cardiomyocytes following both acute and chronic tissue damage events …

Cardiac fibrosis: Pathobiology and therapeutic targets

MP Czubryt, TM Hale - Cellular signalling, 2021 - Elsevier
Cardiac fibrosis is characteristic of the end stage in nearly all forms of heart disease.
Accumulation of extracellular matrix in the myocardium leads to increased risk of arrhythmia …